Dr. Mack Roach
Dr. Mack Roach is recognized as a major authority on the treatment of clinically localized prostate cancer.
He served as lead author for the 1996, 2000 and pending 2006 editions of the American College of Radiology Appropriateness Criteria Guidelines for defining how men in this country should be simulated and treated with radiotherapy. He also served on the NCI Intensity Modulated Radiotherapy Working Group to define jargon and criteria for defining the use of this new technology.
He helped co-author the 2001 prostate cancer screening guidelines put forth by the American Cancer Society.
He is best known for the recently completed prospective randomized RTOG trial that demonstrated the value of pelvic nodal radiotherapy for patients with high risk prostate cancer.
Help other men make better treatment decisions.
A $25 donation today helps us continue the groundbreaking working of the Prostate Cancer Treatment Study Group.